Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | OPTION TO PURCHASE COMMON SHARES | 75K | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director, 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director, 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director, 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director, 10%+ Owner |
LCTX | Lineage Cell Therapeutics, Inc. | Jun 25, 2021 | 2 | $54.4K | 4 | Jun 25, 2021 | Director, 10%+ Owner |